See studies
Back to all studies
RecruitingNCT03495024

Smoking Cessation With Varenicline in Schizophrenia: Antipsychotic-Induced Neurological Symptoms as Correlates

This recruiting study focuses on schizophrenia and currently lists sites or participation links in United States.

SchizophreniaOtherFrom 18 Years to 75 Years
In plain English

Key information made simple

This study exists to see whether smoking support or smoking-related treatment is workable and worth testing more broadly. Researchers are trying to understand whether smoking support or smoking-related treatment can give earlier or clearer feedback during care. For people living with Schizophrenia, being understood earlier and more clearly can shape the whole care journey. If the findings are useful, they could help shape larger studies and better designed support in the future. Taking part helps build the evidence that can improve understanding and care for others over time.

What to expect

Your next step

The official record suggests in-person participation through a hospital, with sites including Corporal Michael J Crescenz VA Medical Center in Philadelphia. Participation appears to involve questionnaires, interviews, or regular check-ins about day-to-day experience. The main fit is usually matching the main diagnosis and meeting the main study requirements, while common reasons not to take part include major medical issues that could make participation unsuitable and active substance or alcohol problems that could affect the results. This is a later-stage study, which usually means the approach is being followed in broader real-world use.

Official source

Registry reference

This page links back to the public source record so people can verify details directly with the registry and research team.

If you want the full study description, eligibility criteria, locations, and sponsor information in the original format, this is the place to check before taking the next step.

Open source record
Interested?

Check my eligibility

Study reference: NCT03495024. Your email is the only field you need to provide here.
In practice

For you

Taking part may give access to a new approach being evaluated.

It requires regular visits and structured follow-up.

Requires travel, with in-person participation in United States.

Important

Not medical advice

Information from public sources. Are you the study sponsor? Contact us to update this page: hi@hopestage.com